{
  "id": 19253719,
  "title": "Bayer wins FDA approval for stroke prevention drug Sunharbo",
  "url": "https://urgent.news/2026/11/10/bayer-wins-fda-approval-for-stroke-prevention-drug-sunharbo",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T00:12:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/bayer-wins-fda-approval-for-stroke-prevention-drug-sunharbo/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Bayer’s asundexian won FDA approval to reduce the risk of stroke in people who recently had a mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. The agency on Monday greenlit the drug in ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke",
        "url": "https://urgent.news/2026/11/09/stat-fda-approves-novel-bayer-drug-to-reduce-recurrence-of-stroke",
        "published": "2026-11-09T22:28:43.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}